Biofarm (Romania) invests 44 million euros in its new production unit
2022-10-132 min.
In Bulgarian In Macedonian In Romanian In Serbian
Biofarm, one of Romania's leading pharmaceutical manufacturers, continues to invest in its new production and testing facility in Bucharest, Balkanengineer.com has learned from Romaniajournal.ro. Thus, the overall investment reaches 44 million euros.

The factory has an area of over 10,000 m2, four production lines and benefits from state-of-the-art equipment and facilities. Among the goals for the next years of the company is to double its turnover, and their focus mainly falls on exports.
The new production base will make a big contribution to achieving this goal. The company currently supplies 25 million units of drugs and nutritional supplements annually, and together with the new manufacturing facility, it will be able to produce up to 100 million units at full capacity, depending on the product mix.
Biofarm is currently ranked in the top 5 manufacturing companies in the Romanian pharmaceutical market, and its products are already active in foreign markets such as Azerbaijan, Iraq, Kyrgyzstan, the Republic of Moldova, Hungary and will soon be found on the shelves of pharmacies in several countries of the Southeast Europe, Central and Southeast Asia, Africa and Arab countries.
Photo source: pixabay.com